Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q1 2022 · 10-Q
Revenue$13.26M$13.26M+8.3% vs Q1 2021 Net Income-$7.21M-$7.21MN/M vs Q1 2021 EPS Diluted-$0.38-$0.38N/M vs Q1 2021 Gross Profit$1,528,000−38.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flow-$609,000N/M Free Cash Flowderived-$612,000— Margins · derivedGross margin11.5%−8.6 pt vs Q1 2021
Operating margin-53.4%+20.5 pt vs Q1 2021
Net margin-54.4%+21.4 pt vs Q1 2021
ended Mar 31, 2022 · filed May 10, 2022 · 40 d after period end